To the full analysis
Organon stock: balance sheet and debt
OGNOrganon has a debt to equity ratio of 11.7 and an interest coverage of 1.8x.
Daily figure as of 13 Nov 2026
Debt / Equity
11.7
Interest coverage
1.8x
Current ratio
1.82
Cash & equivalents
$574M
Total assets
$12.87B
Equity ratio
5.8%
Goodwill
$4.15B
Plus intangible assets of $1.13B
Net debt
$8.23B
Total assets and equity ratio
How large the balance sheet of Organon & Co. is, how much of it is equity and how much is goodwill from acquisitions.
Equity ratio
Figures as a table
| Year | Total assets | Goodwill and intangible assets | of which goodwill | Equity ratio | Net debt |
|---|---|---|---|---|---|
| 2017 | no data | no data | no data | no data | $0 |
| 2018 | $10.49B | $5.42B | $4.6B | 60.5% | −$95M |
| 2019 | $10.55B | $5.17B | $4.6B | 66.7% | −$133M |
| 2020 | $10.11B | $5.11B | $4.6B | 54.3% | $19M |
| 2021 | $10.68B | $5.25B | $4.6B | −14.1% | $8.63B |
| 2022 | $10.96B | $5.25B | $4.6B | −8.1% | $8.41B |
| 2023 | $12.06B | $5.14B | $4.6B | −0.6% | $8.24B |
| 2024 | $13.1B | $6.09B | $4.68B | 3.6% | $8.36B |
| 2025 | $12.87B | $5.28B | $4.15B | 5.8% | $8.23B |
The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt.
Equity and debt
What the company owns and owes
- Cash & equivalents
- Equity
- Debt
Figures as a table
| Year | Cash & equivalents | Equity | Debt | Debt / Equity |
|---|---|---|---|---|
| 2017 | $0 | $0 | $0 | 0 |
| 2018 | $244M | $6.35B | $149M | 0.02 |
| 2019 | $319M | $7.04B | $186M | 0.03 |
| 2020 | $12M | $5.49B | $31M | 0.01 |
| 2021 | $737M | −$1.51B | $9.36B | −6.21 |
| 2022 | $706M | −$892M | $9.11B | −10.22 |
| 2023 | $693M | −$70M | $8.93B | −50 |
| 2024 | $675M | $472M | $9.04B | 19.14 |
| 2025 | $574M | $752M | $8.8B | 11.7 |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 17 Apr 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.